Advertisement

Topics

Companies Related to "Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans" [Most Relevant Company Matches] - Page: 5 RSS

11:37 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans" found in our extensive corporate database of over 50,000 company records.

Showing "Development Algorithm Prediction Onset Hemodynamic Instability Humans" Companies 101–125 of 6,000+

Probably Relevant

Calypte Biomedical Corporation

Calypte Biomedical Corporation is dedicated to developing and marketing in vitro testing algorithms for improved diagnosis of HIV infection, STDs, and other chronic diseases. Calypte is a pioneer in the development of non-blood assays for HIV antibody determination, and is the first and only company to achieve USFDA approval of a urine-based HIV-1 antibody screening test and supplemental Western ...


Icoria

Icoria is a biotechnology company focused on the discovery, development and commercialization of diagnostics and targeted therapeutics in diabetes, obesity, oncology and other areas of unmet medical need. Our objective is to detect and treat disease earlier, preventing the onset of serious illnesses or delaying disease progression to extend lives and improve quality of life for people with early s...

Astero Bio Corporation

Astero Bio Corporation is a leader in novel tools and technologies for life science research, pharmaceutical manufacturing, and clinical applications. Astero specializes in the development and commercialization of next-generation tools to aid in multiple stages of the lifecycles of biologics. Astero’s ThawSTAR® Automated Cell Thawing Systems are...


INSYS Therapeutics/NeoPharm

INSYS Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing innovative products that address chemotherapy-induced nausea and vomiting (CINV), pain management and other central nervous system disorders. We develop new formulations and delivery methods for existing drugs in order to achieve enhanced efficacy, faster onse...

OncoImmunity

OncoImmunity is a machine-learning company offering a proprietary technology to address the key knowledge gaps in the prediction of bone fide immunogenic neoantigens for personalized cancer immunotherapy. OncoImmunity's software facilitates effective patient selection for cancer immunotherapy, and identifies optimal neoantigen targets for truly personal...

Pieces Technologies, Inc.

Pieces Technologies, Inc. is a health information technology company on a mission to advance health at every decision. Pieces Technologies provides end-to-end monitoring, prediction, documentation and discovery software for health systems and community-based organizations. For more information, visit www.piecestech.com or follow @piecestech.

MedCision, LLC.

MedCision develops automation technologies for vital clinical product handling processes. An industry first, the ThawSTAR Automated Cell Thawing System replaces uncontrolled and highly variable manual methods with a customizable algorithm to thaw each unique cell therapy product to maintain maximum cellular efficacy. MedCision’s global customers inclu...

Transplant Genomics Inc.

Transplant Genomics is a molecular diagnostics company committed to improving organ transplant outcomes. Working with the transplant community, TGI will bring vital advances in diagnosis and prediction of transplant status from bench to clinic, supporting clinicians with clear, actionable information to optimize immunosuppression therapy, enhance patient c...

Chondrex, Inc

Chondrex, Inc. provides a variety of high quality reagents and consulting services for arthritis and inflammatory research, under the trade name Arthrogen-CIA®. We specialize in the biochemistry and immunology of collagen and collagen-related materials, as well as arthritis research models (authentic collagen-induced arthritis model and newly developed monoclonal antibody-induced arthritis model...

Natural Cycles

Natural Cycles was founded by husband and wife, Elina Berglund and Raoul Scherwitzl. With PhD’s in physics, they applied their mathematical techniques to developing the Natural Cycles algorithm. Elina was a researcher at CERN and was one of the physicists that discovered the Higgs Boson, which lead to the Nobel Prize in 2013. The Natural Cycles app wa...

Athletigen Technologies Inc.

Athletigen Technologies Inc. is transforming the future for how athletes train. The Company’s interpretive bioinformatics algorithm provides a sports-based DNA analysis to consumers. Athletigen’s easy-to-use, actionable dashboard identifies how a person’s genetics specifically affects their athleticism, nutrition and sports psychology, and creates ...

Xceleron Inc

Pioneer of Acceleratory Mass Spectrometry For Drug Development Xceleron was founded in 1997 in York, UK and has since expanded its operations with a US facility in Maryland, providing bioanalytical accelerator mass spectrometry (AMS) services for accelerated early drug development. The company pioneered human microdose and microtracer techniques using ultra-sensitive AMS to investigate the p...

Genomic Discovery Tools, U.S.

TransFind is a tool for the identification of potential transcription factor complexes several genes in a genelist have in common. TransFind can be used for searching transcription factor binding sites results from MEME , GIBBS , & TESS visually. Transfind can also be used to create an oligonucleotide decoy for a transcription factor of interest and move forward in RNAi target selection. Recent us...

Vaccine and Infectious Disease Organization

VIDO is a world leader in the research and development of vaccine and immunotherapeutic technologies for livestock and humans. It is credited with five "world firsts" in animal vaccine research, and is expanding into human health applications. Current research interests include vaccines against a number of food-borne organisms, and novel vaccine delivery systems including needle-free methods. VIDO...

DARA BioSciences, Inc.

DARA BioSciences, Inc. is a Raleigh, North Carolina based development-stage biopharmaceutical company that acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies. Presently DARA has two drug candidates with cleared IND’s (Investigationa...

Cortexyme, Inc.

Based in South San Francisco, California, Cortexyme is a privately held, clinical-stage pharmaceutical company developing therapeutics to alter the course of Alzheimer’s and other degenerative disorders. Cortexyme is targeting a specific, undisclosed infectious pathogen tied to neurodegeneration and chronic inflammation in humans and animal models. Th...

Genomics Collaborative Incorporated

Genomics Collaborative, Inc's mission is to facilitate the discovery of genes associated with common diseases and the identification of pharmaceutical targets. Genomics Collaborative, Inc. (GCI) has developed an integrated system composed of Global Repository™, GCI Discovery™, an expert genetics team, technology collaborations, and proprietary software.The GCI approach emphasizes problem defin...

Greer

Greer is a leading developer and provider of allergy immunotherapy products and services for treating humans and animals. Greer’s scientists provide technical support for customers by continuing to focus on improving the lives of allergic patients. The company was founded in 1904 and is located in Lenoir, N.C. For more information, visit www.greerlabs...

MedCision, LLC

MedCision develops automation technologies for vital clinical product handling processes. An industry first, the ThawSTAR Automated Cell Thawing System replaces uncontrolled and highly variable manual methods with a customizable algorithm to thaw each unique cell therapy product to maintain maximum cellular efficacy. MedCision’s global customers inclu...

Chondrex, Incorporated

Chondrex, Inc. provides a variety of high quality reagents and consulting services for arthritis and related research, under the trade name Arthrogen-CIA®. Chondrex specialize in the biochemistry and immunology of collagen and collagen-related materials, as well as arthritis research models (authentic collagen-induced arthritis model and newly developed monoclonal antibody-induced arthritis mode...

bioTheranostics, Inc.

bioTheranostics discovers, develops, and commercializes a growing array of molecular diagnostic tests for cancer patients. Leveraging its unique expertise in expression profiling and algorithm development, bioTheranostics is well positioned to be a partner and solution provider in metastatic cancer. The company operates a CLIA-certified, CAP-accredited dia...

Novogen

Novogen's business is in the most pressing area facing medicine in the modern era - that of degenerative diseases and disorders. Cancer Heart disease (stroke, hypertension, coronary artery disease) Osteoporosis Rheumatoid arthritis Inflammatory Bowel Disease (ulcerative colitis, Crohn's Disease) Neurological diseases (Parkinson's Disease, motor neurone disease) Autoimmune diseases (m...

Snooz'n

Snooz'n (www.snoozn.com) is an all-natural, calorie-free and drug-free liquid sleep aid developed to stimulate the onset of sleep naturally, without harmful and uncomfortable side effects. Using 100% natural and preservative-free ingredients, Snooz'n safely and effectively delivers a restful night's sleep to those who need it most - from sleep-deprived travelers to working professionals, busy moms...

InGene

The InGene platform technology is based on a collection of clinical, lifestyle and environmental features obtained from individuals together with their DNA and serum samples integrated into a new type of database.PHENOMEFor data processing, each of the features will be encoded using expert annotation. Thus, a semantically organized data structure is created and integrated into a Medical Knowledge ...

NovaDel Pharma

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations of a broad range of marketed treatments for serious diseases. The Company’s proprietary technology enables rapid delivery of drugs into the bloodstream, which may result in faster onset of action and potential patient benefits in compliance, convenience and safety. NovaDel’s most advanced candidates ...


More From BioPortfolio on "Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks